Evaluation of cardiovascular risk using the Framingham risk score among adults attending a tertiary care centre: a cross-sectional study
DOI:
https://doi.org/10.18203/2349-3933.ijam20263719Keywords:
Framingham risk score, Cardiovascular risk, Tertiary care, India, Hypertension, Diabetes mellitus, Cross-sectional studyAbstract
Background: Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in India. The Framingham risk score (FRS) is a validated tool for estimating 10-year CVD risk; however, data on its applicability in tertiary care settings in Kerala are scarce.
Objective: To evaluate the 10-year cardiovascular risk profile of adults attending a tertiary care centre using the FRS and to identify factors associated with high cardiovascular risk.
Methods: A cross-sectional study was conducted among 450 adults aged 30–75 years attending outpatient departments of a tertiary care centre in Thiruvananthapuram, Kerala, from January to June 2026. The FRS was calculated using standard variables: age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, antihypertensive treatment status, and smoking status. Participants were categorised as low (<10%), intermediate (10-19%), or high (≥20%) risk.
Results: The mean age of participants was 52.4±11.8 years (218 males, 232 females). The overall mean FRS was 17.4±9.2%. A total of 154 participants (34.2%) were categorised as high risk (FRS≥20%), 184 (40.9%) as intermediate risk, and 112 (24.9%) as low risk. Males had a significantly higher mean FRS than females (19.8% vs. 15.3%, p=0.003). Hypertension (OR 2.87; 95% CI 2.14-4.55), diabetes mellitus (OR=2.31), and current smoking (OR=1.94) were the strongest independent predictors of high cardiovascular risk.
Conclusions: A substantial proportion of adults attending this tertiary care centre are at high cardiovascular risk. The FRS is an effective and feasible screening tool in this setting. Targeted interventions addressing hypertension, diabetes, and tobacco use are urgently needed to reduce the CVD burden in this population.
References
Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: current epidemiology and future directions. Circulation. 2016;133(16):1605-20.
Rathod MB, Moukthika S, Karikunnel AJ, Harika K, Talla P, Jalakam M. A Cross-Sectional Evaluation of Cardiovascular Risk Assessment in Type 2 Diabetes Mellitus Patients Using the Framingham Risk Score. Cureus. 2024;16(4):e58026
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982-3021.
Greenland P, Grundy S, Pasternak RC, Lenfant C. Problems on the pathway from risk assessment to risk reduction. Circulation. 1998;97(18):1761-2
Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart. 2006;92(12):1752-9.
Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol. 1992;70(9):945-9.
Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297(3):286-94.
D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53.
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275(20):1571-6.
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-34.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mohammed Rafeequ K., Rakesh M., Salma Anwar, Thameem E. N.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.